AAOS’ Biologics Initiative Gains Momentum

AAOS’ strategic investment in orthobiologics is well underway, overseen by the Committee on Devices, Biologics, and Technology (DBT) and the Council of Research and Quality, with goals to lay a strong, sustainable foundation in 2020, focusing resources toward creating unbiased, evidence-based content, while providing helpful and meaningful position statements, educational programs, regulatory resources, and symposia.